SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001387131-20-005619
Filing Date
2020-06-11
Accepted
2020-06-11 16:02:23
Documents
2
Period of Report
2020-06-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 2769
2 POWER OF ATTORNEY ex24.htm EX-24 9659
  Complete submission text file 0001387131-20-005619.txt   13936
Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP. 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address
BAGGER RICHARD H (Reporting) CIK: 0001372907 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36019 | Film No.: 20957183

Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations